HSA · registration DE0017820Siemens N Antiserum to Human C1-Inhibitor
- Registration number
- DE0017820
- Model name
- N Antiserum to Human C1-Inhibitor; N Protein Standard PY; N Reaction Buffer; N Diluent; N Supplementary Reagent/Precipitation; N/T Protein Control PY
- Model identifier
- OQEY09; OUID13; OUMS61; OUMT05; OUMU15; OWSY13
- Registration date
- January 26, 2016
- Source update date
- October 01, 2024
- Risk class
- Class B
- Product owner
- Siemens Healthcare Diagnostics Products GmbH
- Registrant / registration holder
- SIEMENS HEALTHCARE PTE. LTD.
N Antiserum to Human C1-Inhibitor is an in vitro diagnostic reagent for the quantitative determination of C1-Inhibitor concentration as aid to diagnosis of congenital or acquired C1-Inhibitor deficiencies in patients at risk for or suspected to have C1-Inhibitor deficiency in human serum and sodium citrated plasma by means of automated Siemens Healthineers immuno-nephelometry systems. N Antiserum to Human C1-Inhibitor uses a calibration against an internal protein reference preparation.
- Product owner address
- Emil-von-Behring-Str. 76, 35041 Marburg, Germany
- Registrant address
- 60 MACPHERSON ROAD, THE SIEMENS CENTRE, Singapore 348615
This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.